Earnings estimate | Current qtr. (Jun 2022) | Next qtr. (Sep 2022) | Current year (2022) | Next year (2023) |
---|---|---|---|---|
No. of analysts | 7 | 7 | 24 | 24 |
Avg. Estimate | 29.22 | 38.52 | 121.33 | 130.53 |
Low estimate | 26.8 | 32.98 | 108.6 | 119.53 |
High estimate | 35.38 | 42.4 | 131.3 | 140.9 |
Year ago EPS | 28.1 | 36.6 | 113.2 | 121.33 |
Revenue estimate | Current qtr. (Jun 2022) | Next qtr. (Sep 2022) | Current year (2022) | Next year (2023) |
---|---|---|---|---|
No. of analysts | 7 | 7 | 25 | 25 |
Avg. Estimate | 8.69B | 9.58B | 36.41B | 37.5B |
Low estimate | 8.53B | 9.45B | 34.46B | 36.25B |
High estimate | 8.9B | 9.81B | 37.68B | 39.13B |
Year ago sales | N/A | 9.08B | 34.11B | 36.41B |
Sales growth (year/est) | N/A | 5.50% | 6.70% | 3.00% |
Earnings history | 30/06/2021 | 30/09/2021 | 31/12/2021 | 31/03/2022 |
---|---|---|---|---|
Est. EPS | 20.09 | 29 | 24.52 | 30.16 |
Actual EPS | 28.1 | 36.6 | 25.6 | 32.5 |
Difference | 8.01 | 7.6 | 1.08 | 2.34 |
Surprise % | 39.90% | 26.20% | 4.40% | 7.80% |
EPS trend | Current qtr. (Jun 2022) | Next qtr. (Sep 2022) | Current year (2022) | Next year (2023) |
---|---|---|---|---|
Current estimate | 29.22 | 38.52 | 121.33 | 130.53 |
7 days ago | 29.22 | 38.52 | 121.35 | 130.48 |
30 days ago | 29.75 | 37.66 | 119.87 | 129 |
60 days ago | 29.31 | 37.61 | 119.27 | 127.44 |
90 days ago | 29.9 | 35.9 | 118.23 | 126.25 |
EPS revisions | Current qtr. (Jun 2022) | Next qtr. (Sep 2022) | Current year (2022) | Next year (2023) |
---|---|---|---|---|
Up last 7 days | N/A | 2 | 1 | 2 |
Up last 30 days | 2 | 5 | 11 | 11 |
Down last 7 days | N/A | N/A | N/A | N/A |
Down last 30 days | 2 | N/A | 1 | N/A |
Growth estimates | GSK.L | Industry | Sector(s) | S&P 500 |
---|---|---|---|---|
Current qtr. | 4.00% | N/A | N/A | N/A |
Next qtr. | 5.20% | N/A | N/A | N/A |
Current year | 7.20% | N/A | N/A | N/A |
Next year | 7.60% | N/A | N/A | N/A |
Next 5 years (per annum) | 5.30% | N/A | N/A | N/A |
Past 5 years (per annum) | 11.53% | N/A | N/A | N/A |